Clinical Trial Update: Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome [Phase 2]

View source ↗

Summary

The document describes a Phase 2 clinical trial evaluating the pharmacokinetics, pharmacodynamics, and tolerability of osilodrostat in pediatric patients with C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Syndrome

Drugs mentioned

• Isturisa (osilodrostat)

Snippet

Sponsor: RECORDATI GROUP | Conditions: Cushing Syndrome | Phase 2 | Status: RECRUITING